Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma

References

• RouprêtMZigeunerRPalouJEuropean guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 updateEur Urol201159458459421269756
   PubMed Web of Science ®Google Scholar
• GuptaRPanerGPAminMBNeoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reportingAdv Anat Pathol200815312713918434765
   PubMed Web of Science ®Google Scholar
• ItoAShintakuISatohMProspective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group TrialJ Clin Oncol201331111422142723460707
   PubMed Web of Science ®Google Scholar
• HuangWWHuangHYLiaoACPrimary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resectionPathol Int200959964264919712132
   PubMed Web of Science ®Google Scholar
• NovaraGDe MarcoVDalpiazOIndependent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tractBJU Int2008101111368137418241252
   PubMed Web of Science ®Google Scholar
• SchrierBPHollanderMPvan RhijnBWKiemeneyLAWitjesJAPrognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapyEur Urol200445329229615036673
   PubMed Web of Science ®Google Scholar
• ScarpiniSRouprêtMRenard-PennaRCamparoPCussenotOCompératEImpact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tractUrol Oncol201230218218720189840
   PubMed Web of Science ®Google Scholar
• KrabbeLMBagrodiaALotanYProspective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinomaJ Urol20141911283423871758
   PubMed Web of Science ®Google Scholar
• ZhangXKongCTakenakaIEvaluation of cell proliferation, apoptosis, and angiogenesis in transitional cell carcinoma of the renal pelvis and ureterUrology200157598198511337312
   PubMed Web of Science ®Google Scholar
• AnzickSLKononenJWalkerRLAIB1, a steroid receptor coactivator amplified in breast and ovarian cancerScience199727753289659689252329
   PubMed Web of Science ®Google Scholar
• LiaoLKuangSQYuanYGonzalezSMO’MalleyBWXuJMolecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1J Steroid Biochem Mol Biol2002831–531412650696
   PubMed Web of Science ®Google Scholar
• GnanapragasamVJLeungHYPulimoodASNealDERobsonCNExpression of RAC 3, a steroid hormone receptor co-activator in prostate cancerBr J Cancer200185121928193611747336
   PubMed Web of Science ®Google Scholar
• TannerMMGrenmanSKoulAFrequent amplification of chromosomal region 20q12-q13 in ovarian cancerClin Cancer Res2000651833183910815905
   PubMed Web of Science ®Google Scholar
• GhadimiBMSchröckEWalkerRLSpecific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomasAm J Pathol1999154252553610027410
   PubMed Web of Science ®Google Scholar
• XuFPXieDWenJMSRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomasCancer Lett20072451–2697416458427
   PubMed Web of Science ®Google Scholar
• SakakuraCHagiwaraAYasuokaRAmplification and overexpression of the AIB1 nuclear receptor co-activator gene in primary gastric cancersInt J Cancer200089321722310861496
   PubMed Web of Science ®Google Scholar
• XieDShamJSZengWFCorrelation of AIB1 overexpression with advanced clinical stage of human colorectal carcinomaHum Pathol200536777778316084947
   PubMed Web of Science ®Google Scholar
• LuoJHXieDLiuMZProtein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survivalInt J Cancer2008122112554256118246597
   PubMed Web of Science ®Google Scholar
• GuanXYShamJSTangTCFangYHuoKKYangJMIsolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancerCancer Res20016193806380911325856
   PubMed Web of Science ®Google Scholar
• MarchetAMocellinSBellucoCGene expression profile of primary gastric cancer: towards the prediction of lymph node statusAnn Surg Oncol20071431058106417106627
   PubMed Web of Science ®Google Scholar
• ZhuWCaiMYTongZTOverexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransitionGut201261456257521813470
   PubMed Web of Science ®Google Scholar
• TangDJDongSSMaNFOverexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinomaHepatology20105141255126320112425
   PubMed Web of Science ®Google Scholar
• YangGFXieDLiuJHExpression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinomaGynecol Oncol2009112231431819054548
   PubMed Web of Science ®Google Scholar
• HeLRZhaoHYLiBKOverexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patientsInt J Cancer2011129114315020830705
   PubMed Web of Science ®Google Scholar
• ChenWLuoJHHuaWFOverexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomyCancer Epidemiol Biomarkers Prev200918240040819155439
   PubMed Web of Science ®Google Scholar
• CattoJWAzzouziARAmiraNDistinct patterns of microsatellite instability are seen in tumours of the urinary tractOncogene200322548699870614647464
   PubMed Web of Science ®Google Scholar
• RoupretMCattoJCouletFMicrosatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinomaJ Med Genet2004417e9115235034
   PubMed Web of Science ®Google Scholar
• JouYCTsaiYSChenSYHsiehHYTsaiHTTzaiTSLoss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survivalVirchows Arch2016468673374027003158
   PubMed Web of Science ®Google Scholar
• HallMCWomackSSagalowskyAICarmodyTErickstadMDRoehrbornCGPrognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patientsUrology19985245946019763077
   PubMed Web of Science ®Google Scholar
• GreenDARinkMXylinasEUrothelial carcinoma of the bladder and the upper tract: disparate twinsJ Urol201318941214122123023150
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• TongZTWeiJHZhangJXAIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1Br J Cancer201310871470147923511556
   PubMed Web of Science ®Google Scholar
• GuanXYFungJMMaNFOncogenic role of eIF-5A2 in the development of ovarian cancerCancer Res200464124197420015205331
   PubMed Web of Science ®Google Scholar
• XieDMaNFPanZZOverexpression of EIF-5A2 is associated with metastasis of human colorectal carcinomaHum Pathol2008391808617949776
   PubMed Web of Science ®Google Scholar
• SeisenTPeyronnetBDominguez-EscrigJLOncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelEur Urol20167061052106827477528
   PubMed Web of Science ®Google Scholar
• FangDSeisenTYangKA systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinomaEur J Surg Oncol201642111625163527612412
   PubMed Web of Science ®Google Scholar
• MargulisVShariatSFMatinSFUpper Tract Urothelial Carcinoma CollaborationOutcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma CollaborationCancer200911561224123319156917
   PubMed Web of Science ®Google Scholar
• WuPLiuSZhangWLow-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomyJpn J Clin Oncol201545121175118126450700
   PubMed Web of Science ®Google Scholar
• FujitaKUjikeTNagaharaAEndoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomyInt J Urol201522546346725631522
   PubMed Web of Science ®Google Scholar
• MiyakeHHaraIKamidonoSEtoHMultifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patternsJ Urol200417231127112915311055
   PubMed Web of Science ®Google Scholar
• Millán-RodríguezFChéchile-TonioloGSalvador-BayarriJHuguet-PérezJVicente-RodríguezJUpper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groupsJ Urol200016441183118710992362
   PubMed Web of Science ®Google Scholar
• HabuchiTTakahashiRYamadaHKakehiYSugiyamaTYoshidaOMetachronous multifocal development of urothelial cancers by intraluminal seedingLancet19933428879108710888105314
   PubMed Web of Science ®Google Scholar
• HafnerCKnuechelRZanardoLEvidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tractOncogene200120354910491511521204
   PubMed Web of Science ®Google Scholar
• CattoJWHartmannAStoehrRMultifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJ Urol200617562323233016697867
   PubMed Web of Science ®Google Scholar
• ChromeckiTFBensalahKRemziMPrognostic factors for upper urinary tract urothelial carcinomaNat Rev Urol20118844044721727942
   PubMed Web of Science ®Google Scholar
• LughezzaniGBurgerMMargulisVPrognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literatureEur Urol201262110011422381168
   PubMed Web of Science ®Google Scholar
• XylinasEKluthLPassoniNUTUC CollaborationPrediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making toolEur Urol201465365065824070577
   PubMed Web of Science ®Google Scholar
• HashimotoTNakashimaJKashimaTClinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterecto my for upper tract urothelial carcinomaInt J Urol201724211111627875859
   PubMed Web of Science ®Google Scholar
• XylinasERinkMChaEKUpper Tract Urothelial Carcinoma CollaborationImpact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinomaEur Urol201465121021722579047
   PubMed Web of Science ®Google Scholar
• O’BrienTRayESinghRCokerBBeardRBritish Association of Urological Surgeons Section of OncologyPrevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)Eur Urol201160470371021684068
   PubMed Web of Science ®Google Scholar